AI Analysis
Log in to generate an AI summary for this stock.
Log in to generate a MOAT report for this stock.
Log in to generate an earnings report for this stock.
Log in to generate an operating leverage report for this stock.
Log in to generate a management report for this stock.
Log in to generate a valuation report for this stock.
Magellan Gold Corporation
Video analysis: MAGE
All videosNo video analysis for this stock yet. Request one from our team.
News: MAGE
Magellan Copper and Gold Corp Subsidiary Magellan Energy Corp Enters into Letter of Intent to Acquire Ramm Power Group
WALLACE, ID / ACCESS Newswire / August 18, 2026 / Magellan Copper & Gold Corp. (OTCID:MAGE) ("Magellan" or the "Company") is pleased to announce that the company's wholly owned subsidiary Magellan Energy Corp. has entered a Letter of Intent to acquire Ramm Power Group. Upon closing of the acquisition, the combined companies will be pursuing brownfield development opportunities in the energy production and storage markets.
Magellan Copper and Gold Corp. Forms New Subsidiary Magellan Energy Corp.
WALLACE, ID / ACCESS Newswire / August 13, 2026 / Magellan Copper & Gold Corporation (OTCID:MAGE) ("Magellan" or the "Company"), is pleased to announce that the company has formed a new wholly owned subsidiary, Magellan Energy Corp. The company will pursue opportunities in the energy production and storage markets with an emphasis on brownfield development of efficient energy solutions. Amid an ever-increasing emphasis on data centers to power the new Artificial Intelligence (AI) revolution, the country is seeing huge demand for energy but is stymied in finding faster and more efficient ways to satisfy the increase in demand.
Similar companies
-
Comet Lithium Corporation
XTRRF
·
Other OTC
Compare
-
Tsodilo Resources Limited
TSDRF
·
Other OTC
Compare
-
Hawkeye Gold & Diamond Inc.
HWKDF
·
Other OTC
Compare
-
Mountain Province Diamonds Inc.
MPVDF
·
Other OTC
Compare
-
Riley Gold Corp.
RLYGF
·
Other OTC
Compare
-
Clifton Mining Company
CFTN
·
Other OTC
Compare